Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 6 of 6
Full-Text Articles in Medicine and Health Sciences
A Casereport Of Concomitant Injection Of Botulinum Toxin Type A In Detrusor And External Sphincter For Treatment Of Neurogenic Bladder Dysfunction, Sheng-Wei Zeng, Yu-Hui Huang
A Casereport Of Concomitant Injection Of Botulinum Toxin Type A In Detrusor And External Sphincter For Treatment Of Neurogenic Bladder Dysfunction, Sheng-Wei Zeng, Yu-Hui Huang
Rehabilitation Practice and Science
Patients with spinal cord injury above the sacral level usually have spastic type neurogenic bladder dysfunction (NBD). Spastic NBD is usually manifested with detrusor overactivity and detrusor-external sphincter dyssynergia (DESD). Botulinum toxin type A (BoNT-A) injection has been used in treating spastic NBD for long time. This injection can be performed either on the detrusor (which needs an intermittent catheterization program and a greater decrease in intravesicle pressure) or on the external sphincter (which may cause urinary incontinence and a smaller decrease in intravesicle pressure). Here we present a SCI patient receiving a new injection method involving BoNT-A injection simultaneously …
Effects Of Intraarticular Botulinum Toxin A In The Treatment Of Ankle Osteoarthritis, Shu-Fen Sun, Chien-Wei Hsu, Yi-Jiun Chou, Yu-Nong Wang, Chiao-Wen Hwang, Mei-Chia Chou, Jue-Long Wang
Effects Of Intraarticular Botulinum Toxin A In The Treatment Of Ankle Osteoarthritis, Shu-Fen Sun, Chien-Wei Hsu, Yi-Jiun Chou, Yu-Nong Wang, Chiao-Wen Hwang, Mei-Chia Chou, Jue-Long Wang
Rehabilitation Practice and Science
Background: Preliminary evidence suggests that Botulinum toxin type A (BoNT-A) injected intraarticularly into painful joints has a significant nociceptive effect. The purpose of this study is to investigate the effects of intraarticular BoNT-A on the pain and physical function for patients with ankle osteoarthritis (OA).Method: A prospective study with 6 months follow-up done in a university-affiliated tertiary care medical center, patients with symptoms and radiographic evidence of ankle OA for at least 6 months were recruited. Patients received intraarticular injections of 100 units of BoNT-A in 2 cc of normal saline. The injections were performed by the same experienced doctor. …
Combining Botulinum Toxin Type A Injection And Modified Constraint-Induced Movement Therapy In A Taiwanese Patient With Spastic Hemiplegic Cerebral Palsy: A Casereport, Yi-Chen Tseng, Jui-Yun Su, Yu-Ching Lin
Combining Botulinum Toxin Type A Injection And Modified Constraint-Induced Movement Therapy In A Taiwanese Patient With Spastic Hemiplegic Cerebral Palsy: A Casereport, Yi-Chen Tseng, Jui-Yun Su, Yu-Ching Lin
Rehabilitation Practice and Science
Hypertonia interferes with selective motor control and performance of activities in children with spastic cerebral palsy. At present, most therapists use traditional therapeutic techniques such as neurodevelopmental treatment or other approaches to handle the problems posed by cerebral palsy but the results are not very good. Many studies had shown that botulinum toxin type A (BTX-A) injection can control abnormal muscle tone effectively without major side effects. Constraint-induced movement therapy (CIMT) includes constraint of the sound side upper limb and intensive therapy of the affected limb. In order to reduce spasticity and enhance the use of the affected limb simultaneously, …
Quantitative Emg Evaluation In Spastic Upper Extremity After Botulinum Toxin Injection-A Preliminary Report, Chiao-Wen Hwang, Ching-Hsiang Lu, Pei-Te Sheu, Ya-Wen Hsu, Kun-Shou Tsai, Ji-Long Wang
Quantitative Emg Evaluation In Spastic Upper Extremity After Botulinum Toxin Injection-A Preliminary Report, Chiao-Wen Hwang, Ching-Hsiang Lu, Pei-Te Sheu, Ya-Wen Hsu, Kun-Shou Tsai, Ji-Long Wang
Rehabilitation Practice and Science
Spasticity of the upper limb muscles is a common complication following stroke. Injection of botulinum toxin can decrease upper limb spasticity. The effects of botulinum toxin treatment are usually evaluated by activities of daily living, range of motion (ROM), or modified Ashworth scale. However, in this study, we evaluated the effect of botulinum toxin injection by quantitative EMG, and investigated the relationship between EMG and conventional evaluation methods.Twenty patients with chronic stroke-related spasticity of the upper limb muscles received botulinum injections. All injections were guided by EMG. Outcome measures included total modified Ashworth scale score on the elbow, wrist, metacarpal …
Long-Term Treatment Of Hemifacial Spasm With Type A Botulinum Toxin, Yu-Ching Llin
Long-Term Treatment Of Hemifacial Spasm With Type A Botulinum Toxin, Yu-Ching Llin
Rehabilitation Practice and Science
Hemifacial spasm is a rare movement disorder. It is characterized by recurrent, involuntary tonic or clonic contraction of the muscles innervated by unilateral facial nerve. It may affect patient’s vision and has great cosmetic or psychological impacts. Oral drugs including anticonvulsants, baclofen and benzodiazepines often have little effect. Surgery has potentially serious complications. After numerous clinical studies, botulinum toxin is now recommended as the primary treatment of choice for most hemifacial spasm cases.The purpose of this study is to retrospectively evaluate the dose, effect and side effects of long-term treatment of hemifacial spasm with type A botulinum toxin. Between November …
Clinical Effects Of Botulinum Toxin On Spasticity Management In Children With Cerebral Palsy, En-Shiuan Wu, Chia-Ling Chen, Alice M.K. Wong, Ching-Kai Wong, Jun-Xiao Chen, Shin-Ming Lo
Clinical Effects Of Botulinum Toxin On Spasticity Management In Children With Cerebral Palsy, En-Shiuan Wu, Chia-Ling Chen, Alice M.K. Wong, Ching-Kai Wong, Jun-Xiao Chen, Shin-Ming Lo
Rehabilitation Practice and Science
Botulinum toxin type A (BTA) has treated spasticity in cerebral palsy (CP) in recent years. This study investigated both the clinical effects and gait improvements of BTA on spasticity management in children with CP.Twenty-nine children with spastic CP (2-10 years old) were recruited into this study. All subjects received complete clinical assessments, video recording and functional assessments before and 1-3 months after BTA treatment. A questionnaire was employed for the evaluation of parents’ subjective satisfaction. Clinical assessments included muscle tone and joint range of motion (ROM) of bilateral lower limbs. ROMs, including dynamic (R1) and static (R2), were measured by …